# pathway_0056

[All questions and paired results](../README.md) · [Method](../METHOD.md) · [Source credits](../THIRD_PARTY_NOTICES.md)

**Task:** `pathway`  
**Author expected answer:** **B** — Alkaloid biosynthesis

| Reviewer | Expected-answer support | Reasoning / lookup | Validity |
|---|---|---|---|
| GPT-6 Luna | supported | lookup-dependent | valid_review |
| Qwen3.8-Flash-Next-NVFP4 | supported | reasoning-supported | valid_review |

**Paired comparison:** key agree; reasoning differ. Agreement is not proof of correctness. These are separate AI judgments, with no forced consensus or changed key.

## Complete original question

```text
[Protein Sequence]
MAGKSPEEQHPVKAYGWAARDSSGILSPFKFSRRATGDHDVRVKILYAGVCHSDLQSARNEMGCFTYPLVPGFETVGIATEVGSKVTKMKVGDKVAVGIMVGSCGKCDDCVNDRECYCPEVITSYGRIDHDGTPTYGGFSNETVANEKFVFRFPEKLPMAAGAPLLNAGVSVYSPMRFYGLDKPGMHLGVVGLGGLGHLAVKFAKAFGVKVTVISTSSIKKGEAINDLGADAFLVSTDAKQMQAGSGTLDGILDTVPVVHPIEPLLGLLKNHTKLVLVGATMGSFELPILPLGVGRKSVASTVGGSTTEAQEMLDFAAEHNITANVEIIPMDYINTAMERIEKNDVRYRFVIDVGNTLTPPES

[Multiple Choices]
A. O-acetyl-L-homoserine from L-homoserine: step 1/1. .
B. Alkaloid biosynthesis
C. polypeptide chain elongation. .
D. peptidoglycan biosynthesis. .
```

<details>
<summary>Original system instructions, verbatim</summary>

```text
You are an excellent scientist. Analyze the provided protein-related task carefully and choose the correct answer from the multiple-choice options.

The current task is about Protein Pathway Prediction, which is to predict the primary metabolic or signaling pathway in which a given protein functions. Biological pathways are series of chemical reactions occurring within a cell that are essential for life. Based on the protein's amino acid sequence, you should identify the most relevant pathway from the given options.. The inputs provided by the user for this task include:

* Protein Sequence: The amino acid sequence of the protein.
* Multiple Choices: Candidate answers for the protein-related question.

Please think step-by-step about this problem:
1. Analyze the protein sequence carefully.
2. Consider the biological context and function.
3. Evaluate each multiple-choice option.
4. Provide your reasoning process.
5. Finally, give your answer.

Provide your response in the following format:
1. reasoning: [Your detailed reasoning here]
2. answer: Your final answer, which should be "A", "B", "C" or "D".
```

</details>

## GPT-6 Luna

**Saved status:** `valid_review`.

### Expected-answer support: supported

> The supplied sequence exactly matches the sequence in the UniProt record for 1,2-dihydrovomilenine reductase from Rauvolfia tetraphylla. That record annotates the protein to alkaloid and ajmaline biosynthesis, with an ECO:0000269 evidence tag citing PubMed 26715562. This supports choice B, while remaining a curated annotation tied to that cited study rather than an independent review of the study.

Citations as saved: [C1](#evidence-c1), [C4](#evidence-c4), [C5](#evidence-c5), [C6](#evidence-c6), [H3](#evidence-h3).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

> The sequence is consistent with a soluble oxidoreductase, which makes a ribosomal elongation or peptidoglycan-biosynthesis role unlikely. But that broad inference does not distinguish alkaloid biosynthesis from other metabolic pathways or establish the specific substrate and pathway.


**Missing item-specific fact**

> The protein-specific identity and functional assignment as 1,2-dihydrovomilenine reductase in Rauvolfia alkaloid/ajmaline biosynthesis are absent from the input.


**Reason**

> Selecting B requires the protein-specific pathway annotation or equivalent functional evidence; the sequence and choices alone do not provide a meaningful basis for that precise pathway assignment.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> The sequence-matched functional annotation supports B. The other options are not comparably supported by the supplied sequence, though the pathway choice itself is not inferable from sequence-based general reasoning alone.


### Important caveats

- The annotation and its pathway evidence are reviewer-only and were not supplied to the evaluated model.
- The exact sequence match establishes applicability of the cited record to this sequence, but does not establish which database snapshot the author used.
- The cited publication is associated with the experimental evidence code; its findings were not independently assessed here.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence is consistent with a soluble oxidoreductase, which makes a ribosomal elongation or peptidoglycan-biosynthesis role unlikely. But that broad inference does not distinguish alkaloid biosynthesis from other metabolic pathways or establish the specific substrate and pathway.",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "The protein-specific identity and functional assignment as 1,2-dihydrovomilenine reductase in Rauvolfia alkaloid/ajmaline biosynthesis are absent from the input.",
    "reason": "Selecting B requires the protein-specific pathway annotation or equivalent functional evidence; the sequence and choices alone do not provide a meaningful basis for that precise pathway assignment."
  },
  "case_id": "pathway_0056",
  "expected_answer_check": {
    "evidence_ids": [
      "C1",
      "C4",
      "C5",
      "C6",
      "H3"
    ],
    "judgment": "supported",
    "reason": "The supplied sequence exactly matches the sequence in the UniProt record for 1,2-dihydrovomilenine reductase from Rauvolfia tetraphylla. That record annotates the protein to alkaloid and ajmaline biosynthesis, with an ECO:0000269 evidence tag citing PubMed 26715562. This supports choice B, while remaining a curated annotation tied to that cited study rather than an independent review of the study."
  },
  "important_caveats": [
    "The annotation and its pathway evidence are reviewer-only and were not supplied to the evaluated model.",
    "The exact sequence match establishes applicability of the cited record to this sequence, but does not establish which database snapshot the author used.",
    "The cited publication is associated with the experimental evidence code; its findings were not independently assessed here."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The sequence-matched functional annotation supports B. The other options are not comparably supported by the supplied sequence, though the pathway choice itself is not inferable from sequence-based general reasoning alone."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text
{
  "case_id": "pathway_0056",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The supplied sequence exactly matches the sequence in the UniProt record for 1,2-dihydrovomilenine reductase from Rauvolfia tetraphylla. That record annotates the protein to alkaloid and ajmaline biosynthesis, with an ECO:0000269 evidence tag citing PubMed 26715562. This supports choice B, while remaining a curated annotation tied to that cited study rather than an independent review of the study.",
    "evidence_ids": ["C1", "C4", "C5", "C6", "H3"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "The sequence is consistent with a soluble oxidoreductase, which makes a ribosomal elongation or peptidoglycan-biosynthesis role unlikely. But that broad inference does not distinguish alkaloid biosynthesis from other metabolic pathways or establish the specific substrate and pathway.",
    "missing_item_specific_fact": "The protein-specific identity and functional assignment as 1,2-dihydrovomilenine reductase in Rauvolfia alkaloid/ajmaline biosynthesis are absent from the input.",
    "reason": "Selecting B requires the protein-specific pathway annotation or equivalent functional evidence; the sequence and choices alone do not provide a meaningful basis for that precise pathway assignment."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The sequence-matched functional annotation supports B. The other options are not comparably supported by the supplied sequence, though the pathway choice itself is not inferable from sequence-based general reasoning alone."
  },
  "important_caveats": [
    "The annotation and its pathway evidence are reviewer-only and were not supplied to the evaluated model.",
    "The exact sequence match establishes applicability of the cited record to this sequence, but does not establish which database snapshot the author used.",
    "The cited publication is associated with the experimental evidence code; its findings were not independently assessed here."
  ]
}
```

</details>

## Qwen3.8-Flash-Next-NVFP4

**Saved status:** `valid_review`.

### Expected-answer support: supported

> UniProt entry A0A0U4BHM2 (sequence-exact match, 363 aa) is annotated as '1,2-Dihydrovomilenine reductase' (EC 1.3.1.73) from Rauvolfia tetraphylla, with the pathway explicitly stated as 'Alkaloid biosynthesis; ajmaline biosynthesis' supported by experimental evidence (ECO:0000269, PubMed:26715562). The expected answer 'Alkaloid biosynthesis' is directly confirmed by the UniProt annotation.

Citations as saved: [C4](#evidence-c4), [C5](#evidence-c5), [H3](#evidence-h3), [C6](#evidence-c6).

### Reasoning versus lookup: reasoning-supported

**Discriminating biological argument**

> The sequence contains clear NAD(P)-dependent oxidoreductase motifs (e.g., GGLGHLAVKF and ATMGSFELPILPLGVGRKS representing Rossmann-fold GxGxxG and related NAD(P)-binding patterns), identifying it as an NAD(P)-dependent reductase/dehydrogenase. This enzyme class is inconsistent with Option A (homoserine O-acetyltransferase, EC 2.3.1.31, a transferase requiring acetyl-CoA, not NAD(P)), Option C (polypeptide chain elongation factors, which are GTPases such as EF-Tu/EF-G with distinct GTPase motifs absent here), and Option D (peptidoglycan biosynthesis, a strictly bacterial pathway; the sequence's composition and length are consistent with a plant eukaryotic enzyme, not a bacterial cell-wall enzyme). By elimination based on enzyme-class and organismal inference, Option B (alkaloid biosynthesis, which contains multiple NAD(P)-dependent reductase steps) is the most defensible choice.


**Missing item-specific fact**

> The exact identity of the specific alkaloid sub-pathway (ajmaline biosynthesis) and the precise substrate (1,2-dihydrovomilenine) require database lookup or literature knowledge, but the broader pathway category 'Alkaloid biosynthesis' is reachable by the enzyme-class reasoning above.


**Reason**

> The NAD(P)-binding motifs provide a concrete, general biological argument that distinguishes the reductase from a transferase (A), a GTPase (C), and a bacterial-specific pathway (D). While pinpointing the exact alkaloid sub-pathway requires external knowledge, the question's option set is narrow enough that enzyme-class reasoning meaningfully selects B over the alternatives.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> Options A, C, and D are each inconsistent with the NAD(P)-dependent reductase character of the sequence and/or the eukaryotic/plant context. Only B is compatible with both the enzyme class and the biological context, leaving a single defensible answer.


### Important caveats

- The pathway annotation 'Alkaloid biosynthesis; ajmaline biosynthesis' is supported by experimental evidence (PubMed:26715562, Geissler et al. 2016, Planta), not merely by similarity transfer.
- The organism (Rauvolfia tetraphylla) is not provided in the model input; the inference that this is a plant enzyme (ruling out peptidoglycan) relies on sequence-composition heuristics rather than explicit metadata.
- The EC number 1.3.1.73 for the recommended name is assigned by similarity (ECO:0000250) to A0A0U3S9Q3, while the alternative EC 1.5.1.- is experimentally determined (ECO:0000269). This does not affect the pathway assignment.
- The reviewer-only evidence was not available to the evaluated model; the reasoning assessment is based solely on what a model could infer from the raw sequence and the four options.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence contains clear NAD(P)-dependent oxidoreductase motifs (e.g., GGLGHLAVKF and ATMGSFELPILPLGVGRKS representing Rossmann-fold GxGxxG and related NAD(P)-binding patterns), identifying it as an NAD(P)-dependent reductase/dehydrogenase. This enzyme class is inconsistent with Option A (homoserine O-acetyltransferase, EC 2.3.1.31, a transferase requiring acetyl-CoA, not NAD(P)), Option C (polypeptide chain elongation factors, which are GTPases such as EF-Tu/EF-G with distinct GTPase motifs absent here), and Option D (peptidoglycan biosynthesis, a strictly bacterial pathway; the sequence's composition and length are consistent with a plant eukaryotic enzyme, not a bacterial cell-wall enzyme). By elimination based on enzyme-class and organismal inference, Option B (alkaloid biosynthesis, which contains multiple NAD(P)-dependent reductase steps) is the most defensible choice.",
    "judgment": "reasoning_supported",
    "missing_item_specific_fact": "The exact identity of the specific alkaloid sub-pathway (ajmaline biosynthesis) and the precise substrate (1,2-dihydrovomilenine) require database lookup or literature knowledge, but the broader pathway category 'Alkaloid biosynthesis' is reachable by the enzyme-class reasoning above.",
    "reason": "The NAD(P)-binding motifs provide a concrete, general biological argument that distinguishes the reductase from a transferase (A), a GTPase (C), and a bacterial-specific pathway (D). While pinpointing the exact alkaloid sub-pathway requires external knowledge, the question's option set is narrow enough that enzyme-class reasoning meaningfully selects B over the alternatives."
  },
  "case_id": "pathway_0056",
  "expected_answer_check": {
    "evidence_ids": [
      "C4",
      "C5",
      "H3",
      "C6"
    ],
    "judgment": "supported",
    "reason": "UniProt entry A0A0U4BHM2 (sequence-exact match, 363 aa) is annotated as '1,2-Dihydrovomilenine reductase' (EC 1.3.1.73) from Rauvolfia tetraphylla, with the pathway explicitly stated as 'Alkaloid biosynthesis; ajmaline biosynthesis' supported by experimental evidence (ECO:0000269, PubMed:26715562). The expected answer 'Alkaloid biosynthesis' is directly confirmed by the UniProt annotation."
  },
  "important_caveats": [
    "The pathway annotation 'Alkaloid biosynthesis; ajmaline biosynthesis' is supported by experimental evidence (PubMed:26715562, Geissler et al. 2016, Planta), not merely by similarity transfer.",
    "The organism (Rauvolfia tetraphylla) is not provided in the model input; the inference that this is a plant enzyme (ruling out peptidoglycan) relies on sequence-composition heuristics rather than explicit metadata.",
    "The EC number 1.3.1.73 for the recommended name is assigned by similarity (ECO:0000250) to A0A0U3S9Q3, while the alternative EC 1.5.1.- is experimentally determined (ECO:0000269). This does not affect the pathway assignment.",
    "The reviewer-only evidence was not available to the evaluated model; the reasoning assessment is based solely on what a model could infer from the raw sequence and the four options."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Options A, C, and D are each inconsistent with the NAD(P)-dependent reductase character of the sequence and/or the eukaryotic/plant context. Only B is compatible with both the enzyme class and the biological context, leaving a single defensible answer."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text


{
  "case_id": "pathway_0056",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "UniProt entry A0A0U4BHM2 (sequence-exact match, 363 aa) is annotated as '1,2-Dihydrovomilenine reductase' (EC 1.3.1.73) from Rauvolfia tetraphylla, with the pathway explicitly stated as 'Alkaloid biosynthesis; ajmaline biosynthesis' supported by experimental evidence (ECO:0000269, PubMed:26715562). The expected answer 'Alkaloid biosynthesis' is directly confirmed by the UniProt annotation.",
    "evidence_ids": ["C4", "C5", "H3", "C6"]
  },
  "answerability_check": {
    "judgment": "reasoning_supported",
    "discriminating_biological_argument": "The sequence contains clear NAD(P)-dependent oxidoreductase motifs (e.g., GGLGHLAVKF and ATMGSFELPILPLGVGRKS representing Rossmann-fold GxGxxG and related NAD(P)-binding patterns), identifying it as an NAD(P)-dependent reductase/dehydrogenase. This enzyme class is inconsistent with Option A (homoserine O-acetyltransferase, EC 2.3.1.31, a transferase requiring acetyl-CoA, not NAD(P)), Option C (polypeptide chain elongation factors, which are GTPases such as EF-Tu/EF-G with distinct GTPase motifs absent here), and Option D (peptidoglycan biosynthesis, a strictly bacterial pathway; the sequence's composition and length are consistent with a plant eukaryotic enzyme, not a bacterial cell-wall enzyme). By elimination based on enzyme-class and organismal inference, Option B (alkaloid biosynthesis, which contains multiple NAD(P)-dependent reductase steps) is the most defensible choice.",
    "missing_item_specific_fact": "The exact identity of the specific alkaloid sub-pathway (ajmaline biosynthesis) and the precise substrate (1,2-dihydrovomilenine) require database lookup or literature knowledge, but the broader pathway category 'Alkaloid biosynthesis' is reachable by the enzyme-class reasoning above.",
    "reason": "The NAD(P)-binding motifs provide a concrete, general biological argument that distinguishes the reductase from a transferase (A), a GTPase (C), and a bacterial-specific pathway (D). While pinpointing the exact alkaloid sub-pathway requires external knowledge, the question's option set is narrow enough that enzyme-class reasoning meaningfully selects B over the alternatives."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Options A, C, and D are each inconsistent with the NAD(P)-dependent reductase character of the sequence and/or the eukaryotic/plant context. Only B is compatible with both the enzyme class and the biological context, leaving a single defensible answer."
  },
  "important_caveats": [
    "The pathway annotation 'Alkaloid biosynthesis; ajmaline biosynthesis' is supported by experimental evidence (PubMed:26715562, Geissler et al. 2016, Planta), not merely by similarity transfer.",
    "The organism (Rauvolfia tetraphylla) is not provided in the model input; the inference that this is a plant enzyme (ruling out peptidoglycan) relies on sequence-composition heuristics rather than explicit metadata.",
    "The EC number 1.3.1.73 for the recommended name is assigned by similarity (ECO:0000250) to A0A0U3S9Q3, while the alternative EC 1.5.1.- is experimentally determined (ECO:0000269). This does not affect the pathway assignment.",
    "The reviewer-only evidence was not available to the evaluated model; the reasoning assessment is based solely on what a model could infer from the raw sequence and the four options."
  ]
}
```

</details>

## Existing project source checks of Luna’s review

The notes below were prepared for specific claims in the Luna review. They are not independent validation of Qwen’s claims, expert adjudication, or replacement verdicts.

## Project source-check notes

These project-authored, AI-assisted checks assess specific source claims. They are not expert adjudication and do not replace Luna’s saved review or the author key.

No additional case-specific project note was recorded. Citation membership checks do not establish that every scientific argument is correct.

## Reviewer-only source evidence

**Both reviewers received this source evidence separately from the original question. It was not available to the original evaluated model.** Source support and reasoning from the original sequence/choices are distinct assessments.

**Accession:** `A0A0U4BHM2` (recovered from dataset image-path metadata, not original question text).  
**Sequence applicability:** historical matched; current matched.  
**Historical cutoff:** 2026-05-07; archived entry version 30. Exact author snapshot unknown.

- All evidence and source identity in this section are reviewer-only and were absent from the evaluated model input.
- UniProt annotations may be experimental, computational, or transferred by similarity; evidence codes and qualifiers are retained.
- The 2026-05-07 cutoff approximates the pinned repository date; the author data-construction date and exact source snapshot remain unknown.
- Selected source fields are excerpts; missing annotation is not evidence of falsehood. Primary papers were not comprehensively retrieved or independently validated.

### Evidence C1

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A0U4BHM2.json)  
**Locator:** `/primaryAccession`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-02T04:24:23.340033+00:00.  

```json
"A0A0U4BHM2"
```

Source SHA-256: `c26b85d02403fbdfc042529d2261359bc369b05deb9442cd6e55153bd5141c6f`.

### Evidence C4

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A0U4BHM2.json)  
**Locator:** `/proteinDescription`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-02T04:24:23.340033+00:00.  

```json
{"alternativeNames":[{"fullName":{"evidences":[{"evidenceCode":"ECO:0000303","id":"26715562","source":"PubMed"}],"value":"Protein RR2"},"shortNames":[{"evidences":[{"evidenceCode":"ECO:0000303","id":"26715562","source":"PubMed"}],"value":"RtRR2"}]},{"ecNumbers":[{"evidences":[{"evidenceCode":"ECO:0000269","id":"26715562","source":"PubMed"}],"value":"1.5.1.-"}],"fullName":{"evidences":[{"evidenceCode":"ECO:0000303","id":"26715562","source":"PubMed"}],"value":"Vomilenine reductase 2"},"shortNames":[{"evidences":[{"evidenceCode":"ECO:0000303","id":"26715562","source":"PubMed"}],"value":"RtVR2"}]}],"recommendedName":{"ecNumbers":[{"evidences":[{"evidenceCode":"ECO:0000250","id":"A0A0U3S9Q3","source":"UniProtKB"}],"value":"1.3.1.73"}],"fullName":{"evidences":[{"evidenceCode":"ECO:0000303","id":"26715562","source":"PubMed"}],"value":"1,2-Dihydrovomilenine reductase"},"shortNames":[{"evidences":[{"evidenceCode":"ECO:0000303","id":"26715562","source":"PubMed"}],"value":"RtDHVR"}]}}
```

Source SHA-256: `c26b85d02403fbdfc042529d2261359bc369b05deb9442cd6e55153bd5141c6f`.

### Evidence C5

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A0U4BHM2.json)  
**Locator:** `/comments/5`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-02T04:24:23.340033+00:00.  

```json
{"commentType":"PATHWAY","texts":[{"evidences":[{"evidenceCode":"ECO:0000269","id":"26715562","source":"PubMed"}],"value":"Alkaloid biosynthesis; ajmaline biosynthesis"}]}
```

Source SHA-256: `c26b85d02403fbdfc042529d2261359bc369b05deb9442cd6e55153bd5141c6f`.

### Evidence C6

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A0U4BHM2.json)  
**Locator:** `/references/0`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-02T04:24:23.340033+00:00.  

```json
{"citation":{"authors":["Geissler M.","Burghard M.","Volk J.","Staniek A.","Warzecha H."],"citationCrossReferences":[{"database":"PubMed","id":"26715562"},{"database":"DOI","id":"10.1007/s00425-015-2446-6"}],"citationType":"journal article","firstPage":"813","id":"26715562","journal":"Planta","lastPage":"824","publicationDate":"2016","title":"A novel cinnamyl alcohol dehydrogenase (CAD)-like reductase contributes to the structural diversity of monoterpenoid indole alkaloids in Rauvolfia.","volume":"243"},"evidences":[{"evidenceCode":"ECO:0000312","id":"ALW82982.1","source":"EMBL"}],"referenceNumber":1,"referencePositions":["NUCLEOTIDE SEQUENCE [MRNA]","PROTEIN SEQUENCE OF 14-26 AND 149-156","FUNCTION","CATALYTIC ACTIVITY","PATHWAY","BIOPHYSICOCHEMICAL PROPERTIES"]}
```

Source SHA-256: `c26b85d02403fbdfc042529d2261359bc369b05deb9442cd6e55153bd5141c6f`.

### Evidence H3

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/A0A0U4BHM2?format=txt&versions=30)  
**Locator:** `lines 61-62`  
**Scope:** record released no later than 2026-05-07; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Entry / sequence version:** 30 / 1.  
**Retrieved:** 2026-11-02T04:24:25.840272+00:00.  

```text
CC   -!- PATHWAY: Alkaloid biosynthesis; ajmaline biosynthesis.
CC       {ECO:0000269|PubMed:26715562}.
```

Source SHA-256: `f1ca3ed3dfca81ae192adab6c5b2e6c70586c275e9a49b6b2913846785e88634`.

---

Original question/key: [pinned source](https://github.com/Rongdingyi/LiveProteinBench/blob/8b9710932511f816651fc1a7e8a1bc85c3c77767/dataset/QA/pathway.json), zero-based source row 56. © 2026 LiveProteinBench contributors; [CC BY 4.0](https://huggingface.co/datasets/LiveProteinBench/LiveProteinBench/blob/8428f64e33d53330f7745376d9c45de2d2c37eaf/LICENSE). UniProt and Gene Ontology credits are retained in [source notices](../THIRD_PARTY_NOTICES.md).
